The global enteric disease testing market size reached a value of US$ 3.87 Billion in 2021. Looking forward, IMARC Group expects the market to exhibit stable growth during 2022-2027.
Enteric disease is an intestinal illness caused by microorganisms, such as bacteria, viruses, and parasites,which enter the body through the mouth. Its common symptoms include nausea, vomiting, abdominal cramps and anorexia that can result in the loss of fluids and essential nutrients from the body.At present, there is a rise in the demand for enteric disease testing on account of the improper drainage and sanitation systems in various countries.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Global Enteric Disease Testing Market Trends:
The coronavirus disease (COVID-19) outbreak has increased the need for enteric disease testing across the globe to develop a potential treatment. In addition, the rising prevalence of bacterial disorders, such as intestine infections, polio, typhoid, E.coli and rotavirus,among the massesis propelling the market growth.Moreover, the growing cases of food and water-borne diseases worldwide are driving the market. Apart from this, initiatives undertaken by governments of numerous countries to organize webinars for spreading awareness about the benefits of regular monitoring of enteric disease are projected to stimulate the growth of the market in the upcoming years.
Request Free Sample Report: https://www.imarcgroup.com/enteric-disease-testing-market/requestsample
Global Enteric Disease Testing 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, BD (Becton, Dickinson and Company), Bio-Rad Laboratories Inc., Biomerica Inc., Biomerieux SA, Cepheid Inc. (Danaher Corporation), Coris BioConcept, DiaSorin, Meridian Bioscience Inc. and Quest Diagnostics.
The report has segmented the market on the basis on region, product type, technique, disease type and end-user.
Breakup by Product Type:
Reagents and Consumables
Equipment
Breakup by Technique:
Molecular Diagnostics
Immunodiagnostics
Breakup by Disease Type:
Bacterial Enteric Disease
Viral Enteric Disease
Parasitic Enteric Disease
Breakup by End User:
Hospital Diagnostic Laboratories
Independent Diagnostic Laboratories
Academic and Research Institutes
Others
Breakup by Region:
North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC List of Figure: https://www.imarcgroup.com/enteric-disease-testing-market
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022- 2027)
Porter's Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Other Related Reports:
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact Us:
Company Name: IMARC Group
Email: sales@imarcgroup.com
Toll Free Number: USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
